Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12064407 Endogenous retrovirus-k (ERVK) encodes an alternate envelope protein

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
October 17, 2018
0
Date of Patent
August 20, 2024
0
Patent Applicant
University of Manitoba Press
University of Manitoba Press
0
Patent Application Number
16756947
0
Patent Citations
‌
US Patent 7776523 Endogenous retroviruses up-regulated in prostate cancer
0
‌
US Patent 7205146 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
0
‌
US Patent 7745391 Human thrombospondin polypeptide
0
‌
US Patent 7964341 Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof
0
Patent Inventor Names
Renée Douville
0
Mamneet Gurm
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12064407
0
Patent Primary Examiner
‌
Sikarl A. Witherspoon
0
CPC Code
‌
A61P 31/12
0
‌
A61P 35/00
0
‌
A61K 31/192
0
‌
A61K 31/352
0

Find more entities like US Patent 12064407 Endogenous retrovirus-k (ERVK) encodes an alternate envelope protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo